Related Experiment Videos
Diabetic cardiomyopathy: the significance of creatine
P Guichard1, J E Burkhardt, N W Seidler
1University of Health Sciences, College of Osteopathic Medicine, Department of Biochemistry, Kansas City, Missouri 64124, USA.
Insights
Diabetics face higher cardiovascular disease risks due to intracellular glycation in heart cells. Unphosphorylated creatine may protect diabetic myocytes from toxic glucose metabolites.
Area of Science:
- Cardiovascular Science
- Metabolic Disorders
- Cellular Biology
Background:
- Diabetics have increased cardiovascular disease (CVD) incidence.
- Vascular changes in diabetes, including non-enzymatic glycation, are linked to cardiomyopathy.
- Myocyte pathogenic events may occur independently of atherosclerosis.
Purpose of the Study:
- To investigate intracellular glycation in cardiac tissue of diabetics.
- To explore the role of intracellular glycation in altering intermediary metabolism and Ca2+ homeostasis.
- To examine the potential protective role of unphosphorylated creatine against advanced glycation endproducts (AGEs) in diabetic myocytes.
Main Methods:
- The study hypothesizes intracellular glycation events in cardiac myocytes.
- It proposes investigating alterations in intermediary metabolism and calcium (Ca2+) homeostasis.
- The protective role of creatine against advanced glycation endproducts (AGEs) is hypothesized.
Main Results:
- Intracellular glycation in cardiac tissue is hypothesized to alter metabolism.
- Disrupted Ca2+ homeostasis is proposed as a consequence of intracellular glycation.
- High creatine levels may protect against toxic glucose metabolites.
Conclusions:
- Intracellular glycation contributes to diabetic cardiomyopathy.
- Creatine may serve a protective role in diabetic cardiac myocytes.
- Understanding these mechanisms can inform therapeutic strategies for diabetic cardiovascular complications.
Abstract:
Diabetics exhibit a greater incidence of cardiovascular disease than non-diabetics. The vascular changes that occur are well documented and are thought to promote other clinical manifestations such as cardiomyopathy. Research has shown that the pathogenic events in the myocyte may occur independently of atherosclerotic processes. The atherosclerotic changes in diabetes involve non-enzymatic glycation of extracellular basement membrane proteins. We hypothesize that intracellular glycation events occur in cardiac tissue that alter intermediary metabolism, particularly Ca2+ homeostasis, which leads to cell dysfunction. Additionally, we hypothesize that the high steady state intracellular concentrations of unphosphorylated creatine may offer protection against the formation of advanced glycation endproducts by reacting directly with glucose metabolites that may have reached toxic levels in the myocyte of diabetics.